002198 ST嘉應製藥
按盤價 
3.710 -0.020 (-0.536%)
3.710 -0.020 (-0.536%) | 2026/06 - 中期 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -1.824 | 4.129 | 2.710 | 4.602 | 6.219 |
| 總資產報酬率 ROA (%) | -1.530 | 3.611 | 2.444 | 4.051 | 5.313 |
| 投入資產回報率 ROIC (%) | -1.709 | 3.927 | 2.583 | 4.360 | 5.754 | 邊際利潤分析 |
| 銷售毛利率 (%) | 53.215 | 59.940 | 59.932 | 65.210 | 65.332 |
| 營業利潤率 (%) | -5.983 | 10.387 | 6.714 | 7.598 | 8.174 |
| 息稅前利潤/營業總收入 (%) | -6.659 | 9.801 | 6.307 | 6.992 | 7.471 |
| 淨利潤/營業總收入 (%) | -7.830 | 7.942 | 5.479 | 6.436 | 6.665 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 45.506 | 115.807 | 107.516 | 96.055 | 108.449 |
| 價值變動淨收益/利潤總額(%) | 24.146 | -3.988 | 2.690 | 2.815 | 1.304 |
| 營業外收支淨額/利潤總額(%) | 17.305 | -5.033 | -0.648 | -2.900 | -5.454 | 償債能力分析 |
| 流動比率 (X) | 4.583 | 5.215 | 12.153 | 11.759 | 6.720 |
| 速動比率 (X) | 3.591 | 4.447 | 10.286 | 10.044 | 5.728 |
| 資產負債率 (%) | 16.805 | 15.461 | 9.609 | 9.979 | 13.965 |
| 帶息債務/全部投入資本 (%) | 2.971 | 0.439 | 0.326 | 0.225 | 1.349 |
| 股東權益/帶息債務 (%) | 3,111.394 | 21,622.070 | 29,248.737 | 42,454.284 | 6,972.824 |
| 股東權益/負債合計 (%) | 495.068 | 546.770 | 940.724 | 902.103 | 616.087 |
| 利息保障倍數 (X) | -11.568 | -110.556 | -17.324 | -17.835 | -26.683 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 164.562 | 100.244 | 83.537 | 82.234 | 66.325 |
| 存貨周轉天數 (天) | 209.642 | 186.287 | 202.617 | 161.925 | 122.591 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 10/09/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
